| Product Code: ETC6174078 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Antimicrobial Resistance Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Australia Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Australia Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Australia Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Australia Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Australia Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Australia Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases |
4.2.2 Growing awareness about antimicrobial resistance |
4.2.3 Technological advancements in antimicrobial products |
4.3 Market Restraints |
4.3.1 Limited new antibiotic development |
4.3.2 Stringent regulations for antimicrobial use |
4.3.3 High cost associated with antimicrobial resistance management |
5 Australia Antimicrobial Resistance Market Trends |
6 Australia Antimicrobial Resistance Market, By Types |
6.1 Australia Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Australia Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Australia Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Australia Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Australia Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Australia Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Australia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Australia Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Australia Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Australia Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Australia Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Australia Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Australia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Australia Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Australia Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Australia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Australia Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Australia Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Australia Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Australia Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Australia Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Australia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Australia Antimicrobial Resistance Market Export to Major Countries |
7.2 Australia Antimicrobial Resistance Market Imports from Major Countries |
8 Australia Antimicrobial Resistance Market Key Performance Indicators |
8.1 Number of reported cases of antimicrobial-resistant infections |
8.2 Adoption rate of alternative antimicrobial therapies |
8.3 Investment in research and development for new antimicrobial solutions |
9 Australia Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Australia Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Australia Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Australia Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Australia Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Australia Antimicrobial Resistance Market - Competitive Landscape |
10.1 Australia Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Australia Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here